Table 1.
Clinical parameters | Cases (n) | Expression level | P value (* p < 0.05) | |
---|---|---|---|---|
TPT1-AS1high(n = 59) | TPT1-AS1low(n = 56) | |||
Age(years) | ||||
< 45 years | 33 | 18 | 15 | 0.659 |
≥ 45 years | 82 | 41 | 41 | |
FIGO stage | ||||
I | 67 | 27 | 40 | 0.005* |
II | 48 | 32 | 16 | |
Tumor size (cm) | 0.002* | |||
<4 | 63 | 24 | 39 | |
≥ 4 | 52 | 35 | 17 | |
LNM | 0.028* | |||
Negative | 86 | 39 | 47 | |
Positive | 29 | 20 | 9 | |
Vaginal invasion | 0.752 | |||
Negative | 91 | 46 | 45 | |
Positive | 24 | 13 | 11 | |
Histology | 0.866 | |||
Squamous | 100 | 51 | 49 | |
Adenocarcinoma | 15 | 8 | 7 | |
Parametrail extention | 0.433 | |||
Negative | 102 | 51 | 51 | |
Positive | 13 | 8 | 5 |
FIGO International Federation of Gynecology and Obstetrics, LNM lymph node metastasis
*Statistically significant by Pearson chi-square test